author-photo

Beatriz E. Adrada

University of Texas MD Anderson Cancer Center

43

Papers

81

Citations

Citation Trend

Filter By

Papers (32) Sort By

Journal Conference Others

Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer.

2021 Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Prospective Comparison of Synthesized Mammography with DBT and Full-Field Digital Mammography with DBT Uncovers Recall Disagreements That may Impact Cancer Detection.

2021 Academic Radiology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD6-06: Radiomic phenotypes from dynamic contrast-enhanced MRI (DCE-MRI) parametric maps for early prediction of response to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Bracketing with Multiple Radioactive Seeds to Achieve Negative Margins in Breast Conservation Surgery: Multiple Seeds in Breast Surgery.

2021 Clinical Breast Cancer
Show All
- Source
- Cite
- Save
Citations (1)
MRI features of pseudoangiomatous stromal hyperplasia with histopathological correlation.

2021 Breast Journal
Show All
- Source
- Cite
- Save
Citations (0)
Assessment of Early Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer Using Amide Proton Transfer-weighted Chemical Exchange Saturation Transfer MRI: A Pilot Study.

2021
Show All
- Source
- Cite
- Save
Citations (1)
Abstract PS3-08: Assessment of early response to neoadjuvant systemic therapy (NAST) of triple-negative breast cancer (TNBC) using chemical exchange saturation transfer (CEST) MRI: A pilot study

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Neoadjuvant atezolizumab (atezo) and nab-paclitaxel (nab-p) in patients (pts) with triple-negative breast cancer (TNBC) with suboptimal clinical response to doxorubicin and cyclophosphamide (AC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PS18-04: Prospective evaluation of patients with metaplastic (Mp) triple negative breast cancer (TNBC): Molecular characteristics and outcomes with neoadjuvant therapy (NAT)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD9-05: A tiered algorithm using mid-therapy ultrasound (US) response assessment and a novel gene expression signature (GES) improves the prediction of pathologic complete response (pCR) to neoadjuvant therapy (NAT) in triple-negative breast cancer (TNBC): Results from the ARTEMIS trial (NCT02276443)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)